CSC acquires majority interest in Danish info tech

Article

Looking beyond the U.S. medical market, healthcare consulting firm Computer Sciences Corporation (CSC) has acquired 60% of the Danish information technology company Scandinavian Healthcare Informatics (ScandiHealth). Because ScandiHealth provides IT

Looking beyond the U.S. medical market, healthcare consulting firm Computer Sciences Corporation (CSC) has acquired 60% of the Danish information technology company Scandinavian Healthcare Informatics (ScandiHealth). Because ScandiHealth provides IT services for the Association of County Councils in Denmark, an organization that acts as spokesperson for all Danish county councils in central government matters such as hospital administration, it proved an attractive buy for CSC. Through this acquisition, CSC assumes responsibility for ScandiHealth's long-term contracts with Danish hospitals and thus will become the largest healthcare IT services provider in Denmark. The firm plans to use the Danish market as a springboard to expand its presence in healthcare in other European countries. Terms of the acquisition were not disclosed.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.